In summary, by taking advantage of our network‐driven approach we nominated pathways strongly correlated with AD‐related neuropathological traits and vascular biology that could provide the foundation for our understanding of the mechanisms governing AD‐linked BBB breakdown, dysregulation of the CBF, and pathological accumulation of protein aggregates in human vasculature. The gene discussed is CEBPZ; the disease is Alzheimer disease.